Content about Neurology

September 8, 2010

Residents in North Carolina prescribed controlled substances could receive some attention from more than their...

RALEIGH, N.C. Residents in North Carolina prescribed controlled substances could receive some attention from more than their physicians and pharmacists, according to published reports.

 

September 8, 2010

Safeway announced Wednesday that it raised $11.2 million to benefit the Muscular Dystrophy Association during...

September 6, 2010

Drug maker Somaxon Pharmaceuticals has made its treatment for insomnia available by prescription, the company...

SAN DIEGO Drug maker Somaxon Pharmaceuticals has made its treatment for insomnia available by prescription, the company said Tuesday.

 

Somaxon announced the availability of Silenor (doxepin), which received approval from the Food and Drug Administration in March as a treatment for insomnia characterized by difficulty with sleep maintenance.

 

 

September 1, 2010

The Food and Drug Administration has approved a generic drug made by Actavis for treating...

MORRISTOWN, N.J. The Food and Drug Administration has approved a generic drug made by Actavis for treating attention deficit hyperactivity disorder, Actavis said Wednesday.

 

The FDA approved the drug maker’s atomoxetine hydrochloride capsules in the 10-mg, 18-mg, 25-mg, 40-mg, 60-mg, 80-mg and 100-mg strengths. The drug is a generic version of Eli Lilly’s Strattera, which had $532 million in sales during the 12-month period ended in June, according to IMS Health.

 

 

August 16, 2010

US WorldMeds has acquired Solstice Neurosciences for $35.7 million, US WorldMeds said....

August 1, 2010

The Food and Drug Administration has approved a treatment for muscle spasms and twitches....

GREENSBORO, N.C. The Food and Drug Administration has approved a treatment for muscle spasms and twitches.

 

July 20, 2010

Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant,...

MORRISTOWN, N.J. Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant, the drug maker announced Wednesday.

Actavis said it immediately will begin distributing its bupropion HCl extended-release (SR) tablets in 100-mg and 200-mg strengths. The drug is the generic equivalent of GlaxoSmithKline's Wellbutrin SR. Actavis already has marketed generic Wellbutrin SR in the 150-mg strength. The drug maker received approval in March 2008.

July 18, 2010

Eisai's new drug application for a drug designed as an adjunctive treatment of seizures associated...

July 5, 2010

Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco...

June 20, 2010

U.S. drug maker Valeant and Canadian drug maker Biovail will merge, the two companies said...

June 15, 2010

The Food and Drug Administration has approved a generic drug for anxiety disorder made by...

June 14, 2010

An oral liquid version of an epilepsy drug made by UCB has become available, UCB...

June 3, 2010

The Food and Drug Administration has approved Mylan’s version of a drug for complications related...

June 3, 2010

One-in-5 high school students have abused prescription drugs, according to a survey released Thursday by...

May 25, 2010

Mylan has launched a generic short-term treatment for insomnia, the generic drug maker said Tuesday....

May 3, 2010

The Food and Drug Administration has approved Mylan’s generic version of a smoking-cessation drug, Mylan...

March 30, 2010

XenaCare announced Wednesday that its over-the-counter pain reliever, Cobroxin, will be featured on a segment...

March 24, 2010

The Food and Drug Administration has approved a new use for a drug made by...

March 21, 2010

A once-a-day formulation of a Pfizer drug potentially could capture half of the market for...

March 17, 2010

The Food and Drug Administration has approved a generic anxiety drug made by Actavis, the...

March 10, 2010

An investigational drug can reduce seizures in adolescents and adults with epilepsy when added on...

February 3, 2010

The Food and Drug Administration has approved a new drug for treating major depressive disorder...

January 26, 2010

A topical treatment for post-herpetic neuralgia, more commonly known as shingles, has received an orphan...

January 25, 2010

Teva Pharmaceutical Industries may soon get the green light to market a generic drug for...

January 18, 2010

Watson Pharmaceuticals has filed for regulatory approval of a generic version of a pain drug...